Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: Clinical Efficacy and Safety Evaluation of Teneligliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Empaglyflozin 25 mg and Metformin [Phase 3]
A Phase 3 trial evaluating Teneligliptin added to Empagliflozin 25 mg and Metformin in Type 2 diabetes mellitus with inadequate glycemic con…
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: Study for Multiple Doses of HM15136(Efpegerglucagon) in Obese or Overweight Subjects With Comorbidities [Phase 1]
Phase 1 study evaluating multiple doses of HM15136 (Efpegerglucagon) in obese or overweight adults with comorbidities has completed and resu…
-
EMA approval · 2025-01-27EMA Authorised: Sitagliptin Accord (sitagliptin hydrochloride) — Accord Healthcare S.L.U.
The European Medicines Agency authorised Sitagliptin Accord (sitagliptin hydrochloride) for the treatment of type 2 diabetes mellitus; the p…
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: Observational Study to Evaluate the Efficacy and Safety of Teneligliptin
This update covers a completed observational study evaluating the efficacy and safety of teneligliptin in adults with Type 2 Diabetes Mellit…
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: Postprandial Fatty Acid Metabolism in the Natural History of Type 2 Diabetes (T2D) [NA]
The entry notes that the clinical trial assessing postprandial fatty acid metabolism in the natural history of Type 2 diabetes has completed…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: Exploratory Study to Compare the Effects of Tenelia® or Januvia® on Glucose Variability in add-on to Metformin (CGMS Study) [Phase 4]
Phase 4 exploratory study comparing Tenelia (teneligliptin) versus Januvia (sitagliptin) on glucose variability as add-on to metformin in ad…
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: Effects of Fructose/Glucose-rich Diet on Brown Fat in Healthy Subjects (GB7) [NA]
Completed clinical trial evaluating the effects of a fructose/glucose-rich diet on brown fat in healthy subjects. Type 2 diabetes mellitus i…
-
CLINICAL_TRIALS trial_result · 2025-01-24Clinical Trial Update: Clinical Efficacy and Safety Evaluation of Teneligliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Empaglyflozin and Metformin [Phase 3]
Phase 3 trial evaluating the efficacy and safety of adding Teneligliptin in adults with Type 2 diabetes inadequately controlled on empaglifl…
-
CLINICAL_TRIALS trial_result · 2025-01-24Clinical Trial Update: The Effect of Hypoxia on Type 2 Diabetes and Weight Loss [NA]
Completed clinical trial examining the effect of hypoxia on type 2 diabetes mellitus and weight loss, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-01-24Clinical Trial Update: Measuring the Priorities of Patients With Type II Diabetes Using Likert Scale and Best-worst Scaling
This clinical trial update reports results from a study that measures the priorities of patients with type 2 diabetes using Likert scale met…
-
CLINICAL_TRIALS trial_result · 2025-01-23Clinical Trial Update: A Trial Comparing the Efficacy and Safety of GZR4 Injection Versus Insulin Degludec in Subjects with Type 2 Diabetes Mellitus [Phase 2]
Phase 2 trial comparing GZR4 Injection with insulin degludec in adults with Type 2 diabetes assessed efficacy and safety; the study is compl…
-
CLINICAL_TRIALS research · 2025-01-23Clinical Trial Update: Evaluation of Enavogliflozin's Efficacy and Safety in Type II Diabetes With Hypertension or Dyslipidemia
Clinical trial update indicating Enavogliflozin is recruiting for a study in adults with Type 2 diabetes mellitus, with hypertension or dysl…
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: Native American Diabetes Project [NA]
A University of Southern California–sponsored clinical trial investigating diabetes in Native American populations has been terminated.
-
CLINICAL_TRIALS research · 2025-01-22Clinical Trial Update: Investigation of the Effect of "Curtain" Use on Self-Injection, Testing Fear and Pain in Patients With Type 2 Diabetes [NA]
An ongoing clinical trial from Dicle University investigates whether using a 'Curtain' during self-injection reduces fear and pain in people…
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: COHERE - COntextualized Care in cHcs' Electronic Health REcords [NA]
The COHERE trial evaluating contextualized care in community health centers' electronic health records for hypertension and Type 2 diabetes …
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: Laughter Yoga on Blood Glucose Levels, Disease Perception and Perceived Stress Level [NA]
This clinical trial update reports that a study evaluating laughter yoga's impact on blood glucose, disease perception, and perceived stress…
-
CLINICAL_TRIALS trial_result · 2025-01-20Clinical Trial Update: GLP-1RAs) and SGLT2is Combination Therapy and MACEs in Patients with Type 2 Diabetes.
A completed clinical trial evaluating the combination of GLP-1 receptor agonists and SGLT2 inhibitors for reducing major adverse cardiovascu…
-
CLINICAL_TRIALS trial_result · 2025-01-20Clinical Trial Update: Study to Determine the Prevalence of Hypercortisolism in Patients With Type 2 Diabetes and Treatment With Korlym® (Mifepristone) (CATALYST) [Phase 4]
Phase 4 clinical trial completed to determine how common hypercortisolism is among adults with type 2 diabetes and to evaluate treatment wit…
-
CLINICAL_TRIALS trial_result · 2025-01-20Clinical Trial Update: SGLT2i As Anti Arrhythmic Therapy to Prevent Sudden Cardiac Deaths.
A completed clinical trial (NCT03366181) evaluated whether SGLT2 inhibitors can serve as antiarrhythmic therapy to prevent sudden cardiac de…
-
CLINICAL_TRIALS trial_result · 2025-01-20Clinical Trial Update: An Integrative Study of the Role of Microbiome, Metabolome, Transcriptome and Chronobiology in the Context of Type 2 Diabetes.
Completed clinical trial evaluating how the microbiome, metabolome, transcriptome, and chronobiology relate to Prediabetes and Type 2 Diabet…
-
CLINICAL_TRIALS trial_result · 2025-01-20Clinical Trial Update: Evidence-based Text Messages to Target Diet and Physical Activity [NA]
A completed clinical trial evaluating evidence-based text messages to promote healthier diet and physical activity in adults with type 2 dia…
-
CLINICAL_TRIALS trial_result · 2025-01-17Clinical Trial Update: A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2) [Phase 3]
COMBINE 2 is a Phase 3 study comparing the weekly combo therapy IcoSema (insulin icodec plus semaglutide) to weekly semaglutide in adults wi…
-
CLINICAL_TRIALS trial_result · 2025-01-17Clinical Trial Update: A Study of Cotadutide in Participants Who Have Chronic Kidney Disease With Type 2 Diabetes Mellitus [Phase 2]
A Phase 2 trial of cotadutide in participants with type 2 diabetes mellitus and chronic kidney disease has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2025-01-17Clinical Trial Update: A Trial Comparing Efficacy and Safety of GZR101 and IDegAsp in Insulin Naïve or Insulin Treated Subjects with T2DM [Phase 2]
This Phase 2 trial comparing GZR101 with IDegAsp in insulin-naïve or insulin-treated adults with Type 2 diabetes has completed.
-
EMA safety_alert · 2025-01-17Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 13-16 January 2025
The EMA's Pharmacovigilance Risk Assessment Committee discussed an investigation into a rare eye condition potentially associated with semag…